Biomedical Technology

InnoDrug Lab. (Hongkong) Co., Limited

🚫 No Website Found 🏢 HKSTP Source
58 Potential

Decision Maker

Dr. YI ZHUN ZHU
zhu39@hotmail.com
853 6555 3539
Lab Bench 14a-c, Unit 708-716, 7/F & Room 617, 6/F, Building 17W No. 17 Science Park West Avenue Hong Kong Science Park,Pak Shek Kok,N.T.
Raw Description
InnoDrug Lab. (Hongkong) Co., Ltd was founded by Prof. Yi Zhun ZHU, a Singaporean attracted by the ‘talented program’ by the HK government, who has the rich experience for the drug discovery. He was reported by the most influential scientific magazine Science to be one of the most successful returnee scientists and well-known news magazine in Pharmaceutical industry C&EN as pioneer for drug discovery: he shepherded the development of a cardiovascular drug candidate, leonurine, from discovery to the completion of preclinical studies. || Product | Research and development of SCM-198, ZYZ-802, HDAC4 or JMJD3 and GATA 4 or Fra-1.

Strategic Analysis

Executive Brief

InnoDrug Lab (Hongkong) Co., Ltd is a specialized pharmaceutical R&D firm led by world-class scientists focusing on cardiovascular drug discovery and epigenetic targets (HDAC4, JMJD3). Their workflow involves complex molecular synthesis, preclinical bio-analysis, and the characterization of drug candidates like SCM-198 (Leonurine).

Strategic Fit & Lead Score

Lead Score: 58/100 (Adjacent Tech / Custom R&D)

Why this Score? While InnoDrug is primarily a pharmacology group, their "bottlenecks" lie in the precision of bio-sensing, metabolite detection, and the stability of analytical interfaces. 6C’s Boron-Doped Diamond (BDD) electrodes and Quantum-grade SCD offer transformative advantages for high-sensitivity electrochemical detection and magnetic resonance imaging of cellular responses to cardiovascular drugs.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Metabolite Sensing BDD Electrodes Wide Potential Window: Enables detection of drug metabolites (like Leonurine derivatives) that are electrochemically "silent" on gold or carbon.
Preclinical Screening BDD Biosensors Bio-inertness & Low Fouling: Unlike platinum, BDD resists protein "poisoning," allowing for continuous, real-time monitoring in complex biological fluids.
Cardiac Cell Analysis NV-Center SCD Quantum Magnetic Sensing: Use 6C's SCD to map the magnetic/electric field of cardiomyocytes to observe drug effects on heart cell rhythm at the nanoscale.
Structural Analysis SCD Optical Windows Raman/IR Clarity: Ultra-pure SCD windows for high-pressure or high-temperature spectroscopy during drug synthesis and stability testing.
In-House R&D Custom MPCVD Reactor Vertical Integration: Enable InnoDrug to develop proprietary diamond-based "Lab-on-a-Chip" devices for their unique drug screening protocols.

Engagement Hooks

  • Technical Question: "In your cardiovascular drug screening for candidates like SCM-198, are you encountering signal interference or electrode fouling when measuring oxidative stress markers in biological buffers? Could a BDD-based electrochemical interface improve your detection limits for these small molecules?"

  • Value Statement: "6C can provide InnoDrug with chemically inert, diamond-based sensing platforms that offer the widest electrochemical window available, ensuring your drug discovery process captures metabolites that traditional sensors miss."